- Praxis Precision Medicines Inc Extraordinary Shareholders Meeting TranscriptNov 06, 2023
- Praxis Precision Medicines Inc R&D Day TranscriptOct 02, 2023
- Praxis Precision Medicines Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Praxis Precision Medicines Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Praxis Precision Medicines Inc Essential1 Topline Results Call TranscriptMar 03, 2023
- Praxis Precision Medicines Inc at Citi Biopharma Co-Panel Day (Virtual) - Mood Disorders/Mental Health Panel TranscriptMay 18, 2022
- Praxis Precision Medicines Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Praxis Precision Medicines Inc Earnings Call TranscriptMay 09, 2022$110.85 (-8.54%)Earnings
- Praxis Precision Medicines Inc Epilepsy Day TranscriptApr 27, 2022
- Praxis Precision Medicines Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Q4 2021 Praxis Precision Medicines Inc Earnings Call TranscriptFeb 28, 2022$196.5 (-1.73%)Earnings
- Praxis Precision Medicines Inc Movement Disorder Day TranscriptDec 17, 2021
- Q3 2021 Praxis Precision Medicines Inc Earnings Call TranscriptNov 03, 2021$329.55 (+1.24%)Earnings
- Praxis Precision Medicines Inc at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
- Praxis Precision Medicines Inc Annual Shareholders Meeting TranscriptJun 08, 2021
- Q4 2020 Praxis Precision Medicines Inc Earnings Call TranscriptMar 17, 2021$637.65 (+2.56%)Earnings
Praxis Precision Medicines Inc at Citi BioPharma Conference (Virtual) Transcript
So, good morning, everyone, and thank you for attending Citi's 16th Annual Biopharma Conference. I'm Neena Bitritto-Garg. I'm one of the biotech analysts here, if you don't know me.
And for our next session, I'm really pleased to be joined this morning by leadership from three companies developing drugs in the psychiatric disease and broader CNS space as well: Cerevel, Karuna and Praxis Precision Medicines. So, from Cerevel, we have CMO, Ray Sanchez; from Karuna, we have Steve Paul, CEO; and from Praxis, we have Marcio Souza, CEO as well. And we'll cover some high-level topics this morning in psychiatry; some specific indications, including schizophrenia, DRP and depression; and some specific programs that each of you are developing as well.
Before we get into the discussion, I just wanted to remind the listeners that if you do have a question, feel free to e-mail me directly or you can actually submit questions here at online portal and I'll receive them as well and I'll try to incorporate
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)